Tracking mutations of the coronavirus as it spreads across the world, biologist Emma Hodcroft has become one of Switzerland’s most-followed researchers on Twitter.
Her name has appeared in Wired, the Boston Globe and (German-language media including) the NZZ, but also in the Aargauer Zeitung, Blick and even Nau, a news platform shown on screens in buses, at petrol stations and fitness centres. This is an impressive feat, because Emma Hodcroft, an American-British researcher working in Basel, does pretty complicated research. She is busy mapping mutations of the coronavirus SARS-CoV-2 in real time. But her straightforward communication style has made her one of the best-known faces of science in Switzerland during the pandemic, along with senior experts. “It was heart-warming to be featured in local media. As a foreigner in Switzerland, I felt accepted and valued”, she says, sitting on a metal chair in a park next to her flat in Basel.
But she regrets that the media sometimes badly misrepresent the genetics of coronavirus: “A mistaken narrative keeps popping up: that some types of SARS-CoV-2 would have different epidemiological properties, such as being more or less contagious according to the population at hand. But this is absolutely incorrect. We’ve compared tens of thousands of virus samples from all over the world, looking at mutations where one genetic letter is exchanged for another. And even the two most divergent mutations have no more than 40 such mismatches out of the 29,000 base pairs that contain their whole genetic information. These are very small differences, and have so far shown no impact on the behaviour of the virus”….
Image Credit: Roland Schmid / 13 Photo
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen
News This Week
SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists at Columbia University Vagelos [...]
ANSTO has contributed to a comprehensive investigation of a promising type of nanoparticle that could potentially be used for intractable brain cancers in a combined therapy. The study, which was led by Dr. Moeava [...]
The immune response needed to protect people against reinfection with the coronavirus will be explored in a new human challenge trial, researchers have revealed. Human challenge trials involve deliberately exposing healthy people to a [...]
Researchers from Duke University are developing a flu shot with the new technology that was used for two coronavirus vaccines. Both the Pfizer-BioNTech and the Moderna shots use part of the virus's genetic code [...]
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19. In a paper published in the journal Nanoscale, [...]
Researchers have developed a new superbug-destroying coating that could be used on wound dressings and implants to prevent and treat potentially deadly bacterial and fungal infections. The material is one of the thinnest antimicrobial [...]
The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement Tuesday, the Centers for Disease Control [...]
The South African coronavirus variant is better at "breaking through" the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday. However, one of the authors told AFP that [...]
EPFL scientists have developed AI-powered nanosensors that let researchers track various kinds of biological molecules without disturbing them. The tiny world of biomolecules is rich in fascinating interactions between a plethora of different agents [...]
A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular [...]
Researchers at Brown University have succeeded in creating the first wireless, implantable, rechargeable, long-term brain-computer interface. The wireless BCIs have been implanted in pigs and monkeys for over 13 months without issue, and human [...]
The coronavirus outbreak made household names of companies like Moderna Inc. and BioNTech SE, whose shots offered hope for ending the pandemic. Now a new wave of vaccines is on the horizon that may get the [...]
Researchers at the University of Southampton have developed a new way of using nanomaterials to identify and enrich skeletal stem cells—a discovery which could eventually lead to new treatments for major bone fractures and [...]
In March 2020, Hannu Rajaniemi pivoted his biotech company Helix Nanotechnologies' focus from cancer therapies to Covid-19 vaccines. The role biotech start-ups can play in a pandemic Rajaniemi originally co-founded Helix Nanotechnologies in Cambridge, Massachusetts in [...]
The rapid mass testing strategy costing just £1 a day per child can get children back to school and economies up and running, according to experts. That is the small price of the [...]
Covid-19 vaccines are incredibly good at preventing severe symptoms and hospitalization, but they’re probably less effective at stopping transmission. To do that, we might need a different kind of vaccine altogether. Because SARS-CoV-2 is [...]